comprehensive -WSS

comprehensive

author：comprehensive 2025-09-06 09:10:22 - browse：65452

The Food and Drug Administration on Friday approved the world’s first medicine based on CRISPR gene-editing technology, a groundbreaking treatment for sickle cell disease that delivers a potential cure for people born with the chronic and life-shortening blood disorder.

The new medicine, called Casgevy, is made by Vertex Pharmaceuticals and CRISPR Therapeutics. Its authorization is a scientific triumph for the technology that can efficiently and precisely repair DNA mutations — ushering in a new era of genetic medicines for inherited diseases.

In a clinical trial, Casgevy was shown to eliminate recurrent episodes of debilitating pain caused by sickle cell, which afflicts approximately 100,000 people in the U.S., a vast majority of whom are Black. The therapy, whose scientific name is exa-cel, is described as a potential cure because the genetic fix enabled by CRISPR is designed to last a lifetime, although confirmation will require years of follow-up.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The cancer drug shortage isn’t new — and neither are the solutions
Next article： World's first CRISPR

WSS

U.K. considers world's first use of meningitis vaccine to address gonorrhea

Readout LOUD podcast: A CRISPR milestone, biotech mixology

Three trends to watch in biotech in 2024

Readout Newsletter: The latest on Moderna, Apellis, and Merck

HCA sued by state AG for quality issues at Mission Health

Grail spinoff by Illumina should end disastrous merger attempt

focus

comprehensive

knowledge

George Santos makes 1st court appearance after pleading not guilty to 13 counts

CRISPR pioneers react to Casgevy, first gene

Peter Hotez and the public health issue of online harassment

Morphosys mixed study results for blood cancer drug

The high cost of giving birth even with insurance

Advocates call out 'SNL' over stereotypes, errors in sickle cell skit

Affirmative action in medical school literally saved lives

Can sheer will power keep patients alive in their dying hours?

What does generative AI mean for health care? We asked experts

Readout Newsletter: Bayer's future, Merck Caraway acquisition, etc

hotspot

Why health care costs have stayed mostly flat since 2010

PBM reforms clear House panel

Hospitals look to new technology to keep health care workers safe

In Spain, a hospital brews its own CAR

Grail spinoff by Illumina should end disastrous merger attempt

In key trial, Verve's treatment lowers cholesterol levels in patients

Wikipedia

Wikipedia

leisure time

knowledge